{"nct_id":"NCT02612311","title":"Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Participants With Untreated and Previously Treated Chronic Lymphocytic Leukemia","status":"TERMINATED","status_verified_date":"2024-11","start_date":"2015-11-19","start_date_type":"ACTUAL","primary_completion_date":"2023-02-22","primary_completion_date_type":"ACTUAL","completion_date":"2023-02-22","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TGTX"]}